Fundraising Fox

DisperSol Technologies

Georgetown, US · Founded 2007 · Texas LLC · 1 known investors

Biotech

Founders & leadership

SK
Shaun KirkpatrickExecutive
GY
Gershon YanivExecutive
DS
Dustin SmithExecutive
ER
Edward R. HobartExecutive

Board

JS
Jeffrey SambergBoard director
CB
Chris BroughBoard director
JM
James MackBoard director

Investors · 1

Research Corporation TechnologiesreportedTucson

Reported raises · per SEC filings

Form D private placements

$36.4M disclosed across 5 rounds · 2012–2020

▶$4.7MraisedOct 2020 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James MackDirector
  • Gershon YanivDirector
  • Jeffrey D. SambergDirector
  • Shaun KirkpatrickDirector
  • Edward M. Rudnic, Ph.D.Executive Officer, Director
Offering amount
$5M
Amount sold
$4.7M
First sale
Oct 2020
Incorporated
Limited Liability Company, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16MraisedJan 2018 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey D. SambergDirector
  • James MackDirector
  • Gershon YanivDirector
  • Edward M. Rudnic, Ph.D.Executive Officer, Director
  • Shaun KirkpatrickDirector
Offering amount
$27.3M
Amount sold
$16M
First sale
Jan 2018
Incorporated
Limited Liability Company, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedFeb 2016 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Shaun KirkpatrickExecutive Officer, Director
  • James MackDirector
  • Gershon YanivExecutive Officer, Director
  • Dustin SmithExecutive Officer
  • Jeffrey SambergDirector
Offering amount
$12M
Amount sold
$12M
First sale
Jan 2016
Incorporated
Limited Liability Company, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedMar 2014 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Chris BroughDirector
  • Edward HobartExecutive Officer, Director
  • Gershon YanivExecutive Officer, Director
  • Jeffrey D. SambergDirector
Offering amount
$7.5M
Amount sold
$3M
Finders' fees
$150K
First sale
Feb 2014
Incorporated
Limited Liability Company, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$641.7KraisedFeb 2012 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gershon YanivExecutive Officer, Director
  • Chris BroughDirector
  • Jeffrey D. SambergDirector
  • Edward R. HobartExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$641.7K
First sale
Jan 2012
Incorporated
Limited Liability Company, Texas, 2007
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

AustinPx™ | Research Corporation TechnologiesResearch Corporation Technologiesrctech.com · Aug 2022DisperSol Technologies Raises $27M in Financing - FinSMEsfinsmes.com · Apr 2018Central Texas biomedical company DisperSol raises $12 millionstatesman.com · Sep 2016DisperSol Technologies Secures over $10 million in Financing Led by RCT | Research Corporation TechnologiesResearch Corporation Technologiesrctech.com · Feb 2015

Frequently asked questions

Who are DisperSol Technologies's investors?
DisperSol Technologies's investors include Research Corporation Technologies.
How much funding has DisperSol Technologies raised?
DisperSol Technologies has disclosed $36.4M raised across 5 rounds.
Where is DisperSol Technologies headquartered?
DisperSol Technologies is headquartered in Georgetown, US.